

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation and neurodegenerative diseases. Among its major competitors, Reata Pharmaceuticals is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $2.95B